Without doubt, identifying major factors triggering this phenomenon is a prerequisite for developing effective strategies to attenuate the process oscillation.
If exercise can delay or attenuate the process of immunosenescence, a clinical benefit that one may expect to observe is a reduction in the incidence or severity of infectious disease.
Diaphragmatic muscle weakening is partially explained by proteolysis, apoptosis and oxidative stress [ 3], and appears to be directly proportional to duration of mechanical ventilation [ 4]; anti-oxidant and anti-inflammatory agents such as steroids may attenuate the process [ 5, 6].
Env genes, required for retroviral infectivity, are not thought to be required for retrotransposition, and it is possible that for some retroelements the gene or its protein product might attenuate the process, promoting selection for their inactivation, but with concomitant loss of infectivity.
Overall, these data provide the first evidence for non-repair functions of MGMT in cell cycle and highlight the involvement of PCNA in MGMT downregulation, with p21 attenuating the process.
Induction of protein degradation and expression of the ubiquitin proteasome pathway through activation of NF- κB would provide a mechanism to explain the effect of EPA in attenuating the process in cachectic mice (Whitehouse et al, 2001).
Experimental results indicated that ethanol inhibition rather than osmotic stress on yeast cells is one of the main factors triggering the process oscillation under the VHG fermentation condition, and in the meantime gas stripping was validated to be an effective strategy for attenuating the process oscillation.
In conclusion, we have demonstrated that treatment with HNHA, a new HDAC inhibitor, markedly attenuated the process of liver fibrosis both in vitro and in vivo, showing a marked decrease of HSC proliferation and increased apoptosis, as well as suppression of profibrogenic factors such as PDGF and TGF-β1.
Removal of aggregates can occur via different cellular processes, which, depending on the milieu, may aggravate or attenuate the disease process associated with Alzheimer's, Parkinson's, Huntington's, prion diseases, frontotemporal dementia, and motor neuron disease.
Increasing evidence showed that unlike gene mutation or deletion, epigenetic changes during the aging process of organism can be reversed, making it a promising target to attenuate the aging process.
Use of rhAPC in this group may attenuate the disease process and reduce the potential morbidity associated with this iatrogenic disorder.
